Top

BMC Complementary Medicine and Therapies

Published in:

Open Access 01-12-2017 | Research article

Direct and indirect risk associated with the use of dietary supplements among persons with dementia in a Norwegian memory clinic

Authors: Hilde Risvoll, Trude Giverhaug, Kjell H. Halvorsen, Marit Waaseth, Frauke Musial

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Abstract

Background

The use of dietary supplements (DS) is common among persons with dementia. Direct risks associated with DS use include adverse events and DS-drug interactions. A direct risk is a risk caused by the treatment itself. Indirect risks are related to the treatment setting, such as the conditions of use, and not to the treatment itself. Because dementia symptoms may reduce a person’s ability to cope with the administration of DS, the use of DS may pose a threat to safety as an indirect risk. The aim of this study was to describe the extent of DS use among persons with dementia in ambulatory care and to identify some relevant direct and indirect risks related to DS use.

Methods

We conducted a survey among 151 persons with dementia attending an outpatient memory clinic in Northern Norway. Study measurements included: the participants’ characteristics, cognitive functioning, functioning in the activities of daily living (ADL), and the use of DS and prescription drugs (PD). We assessed direct risks by evaluating potential DS-drug interactions and indirect risks by evaluating the conditions under which it was used.

Results

Forty-six percent (n = 70) of the persons with dementia used DS. Ninety-seven percent (n = 147) used PD. We found potentially clinically relevant DS-drug interactions representing a direct risk in eight persons with dementia (11% of users). While only 36% (n = 26) of the participants received assistance with the administration of DS, 73% (n = 106) received assistance with the administration of PD. Persons with dementia living alone were at risk of not receiving assistance, as home care service seldom was involved in DS administration. Data indicated that assistance with DS administration was not provided for all persons with dementia in need, representing an indirect risk to these persons. Only one-third of the persons with dementia and half of the caregivers were aware of the general risks of adverse events and interactions associated with the use of DS.

Conclusions

Persons with dementia use DS frequently, yet DS use may be associated with direct and indirect risks to patient safety as potentially clinically relevant interactions were discovered and DS intake often was unsupervised.

Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15(5):455–532. doi:10.1016/s1474-4422(16)00062-4.CrossRefPubMed

Sydenham E, Dangour AD, Lim WS. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev. 2012;6:Cd005379. doi:10.1002/14651858.CD005379.pub3.

Persson T, Popescu BO, Cedazo-Minguez A. Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail? Oxidative Med Cell Longev. 2014;2014:427318. doi:10.1155/2014/427318.CrossRef

Obermann KR, Morris JC, Roe CM. Exploration of 100 commonly used drugs and supplements on cognition in older adults. Alzheimers Dement. 2013;9(6):724–32. doi:10.1016/j.jalz.2012.12.002.CrossRefPubMed

Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2009;1:Cd003120. doi:10.1002/14651858.CD003120.pub3.

Dhikav V, Anand KS. Complementary and alternative medicine usage among Alzheimer's disease patients. Int Psychogeriatr. 2012;24(8):1361–2. doi:10.1017/s1041610212000427.CrossRefPubMed

Hogan DB, Ebly EM. Complementary medicine use in a dementia clinic population. Alzheimer Dis Assoc Disord. 1996;10(2):63–7. doi:10.1097/00002093-199601020-00002.CrossRefPubMed

Landin J, Frolich L, Schwarz S. Use of alternative therapies in patients with dementia and mild cognitive impairment: a prospective, controlled study. International Journal of Geriatric Psychiatry. 2008;23(11):1163–5. doi:10.1002/gps.2046.CrossRefPubMed

Coleman LM, Fowler LL, Williams ME. Use of unproven therapies by people with Alzheimer's disease. J Am Geriatr Soc. 1995;43(7):747–50. doi:10.1111/j.1532-5415.1995.tb07043.x.CrossRefPubMed

10.

Dergal JM, Gold JL, Laxer DA, Lee MS, Binns MA, Lanctot KL, et al. Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic. Drugs Aging. 2002;19(11):879–86. doi:10.2165/00002512-200219110-00005.CrossRefPubMed

11.

Laporte Uribe F, Heinrich S, Wolf-Ostermann K, Schmidt S, Thyrian JR, Schafer-Walkmann S, et al. Caregiver burden assessed in dementia care networks in Germany: findings from the DemNet-D study baseline. Aging Ment Health. 2016:1–12. doi:10.1080/13607863.2016.1181713.

12.

Bunchorntavakul C, Reddy KR. Review article: herbal and dietary supplement hepatotoxicity. Aliment Pharmacol Ther. 2013;37(1):3–17. doi:10.1111/apt.12109.CrossRefPubMed

13.

Ernst E. Harmless herbs? A review of the recent literature. Am J Med. 1998;104(2):170–8. doi:10.1016/s0002-9343(97)00397-5.CrossRefPubMed

14.

Kupiec T, Raj V. Fatal seizures due to potential herb-drug interactions with Ginkgo biloba. J Anal Toxicol. 2005;29(7):755–8. doi:10.1093/jat/29.7.755.CrossRefPubMed

15.

Chan TY. Contributory factors in herb-induced fatal aconite poisoning. Forensic Sci Int. 2012;223(1–3):40–3. doi:10.1016/j.forsciint.2012.10.009.CrossRefPubMed

16.

Shalansky S, Lynd L, Richardson K, Ingaszewski A, Kerr C. Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis. Pharmacotherapy. 2007;27(9):1237–47. doi:10.1592/phco.27.9.1237.CrossRefPubMed

17.

Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, et al. Herb-drug interactions: a literature review. Drugs. 2005;65(9):1239–82. doi:10.2165/00003495-200565090-00005.CrossRefPubMed

18.

Wardle JL, Adams J. Indirect and non-health risks associated with complementary and alternative medicine use: An integrative review. European Journal of Integrative Medicine. 2014;6(4):409–22. doi:10.1016/j.eujim.2014.01.001.CrossRef

19.

Stub T, Salamonsen A, Kristoffersen A, Musial F. How to handle worsening of condition during treatment - risk assessment in homeopathic practice. Forsch Komplementmed. 2015;22(1):30–5. doi:10.1159/000377644.CrossRefPubMed

20.

Chan K. Some aspects of toxic contaminants in herbal medicines. Chemosphere. 2003;52(9):1361–71. doi:10.1016/s0045-6535(03)00471-5.CrossRefPubMed

21.

Vaclavik L, Krynitsky AJ, Rader JI. Mass spectrometric analysis of pharmaceutical adulterants in products labeled as botanical dietary supplements or herbal remedies: a review. Anal Bioanal Chem. 2014;406(27):6767–90. doi:10.1007/s00216-014-8159-z.CrossRefPubMed

22.

Shaw D, Ladds G, Duez P, Wiliamson E, Chan K. Pharmacovigilance of herbal medicine. J Ethnopharmacol. 2012;140(3):513–8. doi:10.1016/j.jep.2012.01.051.CrossRefPubMed

23.

Owens C, Baergen R, Puckett D. Online sources of herbal product information. Am J Med. 2014;127(2):109–15. doi:10.1016/j.amjmed.2013.09.016.CrossRefPubMed

24.

Raynor DK, Dickinson R, Knapp P, Long AF, Nicolson DJ. Buyer beware? Does the information provided with herbal products available over the counter enable safe use? BMC Med. 2011;9:94. doi:10.1186/1741-7015-9-94.CrossRefPubMedPubMedCentral

25.

Hayward RA, Asch SM, Hogan MM, Hofer TP, Kerr EA. Sins of omission: getting too little medical care may be the greatest threat to patient safety. J Gen Intern Med. 2005;20(8):686–91. doi:10.1111/j.1525-1497.2005.0152.x.CrossRefPubMedPubMedCentral

26.

Ernst E. Complementary medicine: its hidden risks. Diabetes Care. 2001;24(8):1486–8. doi:10.2337/diacare.24.8.1486.CrossRefPubMed

27.

Kemper KJ, Gardiner P, Gobble J, Woods C. Expertise about herbs and dietary supplements among diverse health professionals. BMC Complement Altern Med. 2006;6:15. doi:10.1186/1472-6882-6-15.CrossRefPubMedPubMedCentral

28.

Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98. doi:10.1002/(sici)1099-1166(199805)13:5<285::aid-gps753>3.3.co;2-m.CrossRefPubMed

29.

Strobel C, Engedal K: MMSE-NR2 (MMS - norsk revisjon) (article in Norwegian language). Available at: file:///C:/Users/uin/Downloads/Manual%20MMSE-NR.pdf Assessed: 10 May 2016.

30.

Linn MW, Linn BS. The rapid disability rating scale-2. J Am Geriatr Soc. 1982;30(6):378–82. doi:10.1111/j.1532-5415.1982.tb02835.x.CrossRefPubMed

31.

Krueger CE, Bird AC, Growdon ME, Jang JY, Miller BL, Kramer JH. Conflict monitoring in early frontotemporal dementia. Neurology. 2009;73(5):349–55. doi:10.1212/WNL.0b013e3181b04b24.CrossRefPubMedPubMedCentral

32.

Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993;269(18):2386–91. doi:10.1001/jama.269.18.2386.CrossRefPubMed

33.

U.S. Department of Health & Human Services. Dietary Supplement Health and Education Act of 1994. Public Law No. 103–417. Paragraph 3a. In: Health NIo, vol. 2016. U.S.: Department of Health & Human Services; National Institute of Health; 1994.

34.

Khurshid Z, Zafar MS, Zohaib S, Najeeb S, Naseem M. Green Tea (Camellia sinensis): Chemistry and Oral Health. Open Dent J. 2016;10:166–73. doi:10.2174/1874210601610010166.CrossRefPubMedPubMedCentral

35.

Inrstitute of Medicine Panel on M. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington D.C.: National Academies Press (US); 2001. p. 197–257. doi:10.17226/10026.

36.

Vieth R. Vitamin D toxicity, policy, and science. J Bone Miner Res. 2007;22(Suppl 2):V64–8. doi:10.1359/jbmr.07s221.CrossRefPubMed

37.

Waaseth M, Nakling M, Bakken K, Grimsgaard S. Use of dietary supplements and medication among postmenopausal women with vasomotor symptoms. Climacteric. 2010;13(6):585–93. doi:10.3109/13697130903480714.CrossRefPubMed

38.

Djuv A, Nilsen OG, Steinsbekk A. The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study. BMC Complement Altern Med. 2013;13:295. doi:10.1186/1472-6882-13-295.CrossRefPubMedPubMedCentral

39.

Wachira JK, Larson MK, Harris WS: n-3 Fatty acids affect haemostasis but do not increase the risk of bleeding: clinical observations and mechanistic insights. Br J Nutr. 2014; 111(9):1652-1662. doi:10.1017/s000711451300425x.

40.

Bush TM, Rayburn KS, Holloway SW, Sanchez-Yamamoto DS, Allen BL, Lam T et al: Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey. Altern Ther Health Med. 2007;13(2):30-35. Retrieved from http://search.proquest.com/docview/204836174?accountid=26469.

41.

Stein J, Luppa M, Maier W, Wagner M, Wolfsgruber S, Scherer M, Kohler M, Eisele M, Weyerer S, Werle J et al: Assessing cognitive changes in the elderly: reliable change indices for the Mini-Mental State Examination. Acta Psychiatr Scand. 2012;126(3):208-218.

42.

Sinclair AJ, Girling AJ, Bayer AJ: Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. Diabetes Res Clin Pract. 2000;50(3):203-12. doi:10.1016/S0168-8227(00)00195-9.

43.

Gellad WF, Grenard JL, Marcum ZA: A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011; 9(1):11-23. doi:10.1016/j.amjopharm.2011.02.004.

44.

Awad A, Al-Shaye D: Public awareness, patterns of use and attitudes toward natural health products in Kuwait: a cross-sectional survey. BMC Complement Altern Med. 2014;14:105. doi:10.1186/1472-6882-14-105.

45.

Weinstein ND, Klein WM. Resistance of personal risk perceptions to debiasing interventions. Health Psychol. 1995;14(2):132-40. doi:10.1037/0278-6133.14.2.132.

46.

Maher RL, Hanlon J, Hajjar ER: Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57-65. doi:10.1517/14740338.2013.827660.

47.

Stocks SJ, Kontopantelis E, Akbarov A, Rodgers S, Avery AJ, Ashcroft DM. Examining variations in prescribing safety in UK general practice: cross sectional study using the Clinical Practice Research Datalink. BMJ. 2015;351. doi:10.1136/bmj.h5501.

48.

Meeuwsen EJ, Melis RJ, Van Der Aa GC, Goluke-Willemse GA, De Leest BJ, Van Raak FH et al. Effectiveness of dementia follow-up care by memory clinics or general practitioners: randomised controlled trial. BMJ. 2012;344:e3086. doi:10.1136/bmj.e3086.

49.

Henriksen K, Østby L, Ellingsen D: Immigration and immigrants 2010. Available at http://www.ssb.no/a/english/publikasjoner/pdf/sa122/sa122_en.pdf. Accessed 1 May 2017.

Title: Direct and indirect risk associated with the use of dietary supplements among persons with dementia in a Norwegian memory clinic
Authors: Hilde Risvoll
Trude Giverhaug
Kjell H. Halvorsen
Marit Waaseth
Frauke Musial
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI: https://doi.org/10.1186/s12906-017-1765-5

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Direct and indirect risk associated with the use of dietary supplements among persons with dementia in a Norwegian memory clinic

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2017

Assessment of herbal drugs for promising anti-Candida activity

Molecular network-based analysis of the mechanism of liver injury induced by volatile oils from Artemisiae argyi folium

IL-1β-induced modulation of gene expression profile in human dermal fibroblasts: the effects of Thai herbal Sahatsatara formula, piperine and gallic acid possessing antioxidant properties

Extract of Synedrella nodiflora (L) Gaertn exhibits antipsychotic properties in murine models of psychosis

Chemical composition and anti-herpes simplex virus type 1 (HSV-1) activity of extracts from Cornus canadensis

Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat study